000 01471 a2200409 4500
005 20250515074532.0
264 0 _c20070910
008 200709s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/1471-2407-7-131
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVinayagam, Raman
245 0 0 _aAssociation of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study.
_h[electronic resource]
260 _bBMC cancer
_cJul 2007
300 _a131 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents, Hormonal
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xbiosynthesis
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
_xmethods
650 0 4 _aCohort Studies
650 0 4 _aEstrogen Receptor beta
_xbiosynthesis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Rate
_xtrends
650 0 4 _aTreatment Outcome
700 1 _aSibson, D Ross
700 1 _aHolcombe, Christopher
700 1 _aAachi, Vijay
700 1 _aDavies, Michael Pa
773 0 _tBMC cancer
_gvol. 7
_gp. 131
856 4 0 _uhttps://doi.org/10.1186/1471-2407-7-131
_zAvailable from publisher's website
999 _c17174656
_d17174656